0 NASDAQ Companies - November 20, 2019T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ PanelLEXINGTON, Mass., Nov. 20, 2019 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of […]Read More
0 TSX Venture News - November 20, 2019Visionstate Announces Collaboration with Bunzl on New IoT TechnologyEDMONTON, Alberta, Nov. 20, 2019 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate” or ‘the Company”) is pleased to announce […]Read More
0 NYSE Companies - November 20, 2019Amazon Prime Video now available on Ignite TVInnovative TV service gets even better with the integration of the Prime Video appIgnite customers can search and navigate Amazon […]Read More
0 NYSE Companies - November 20, 2019Amazon Prime Video maintenant offert sur la Télé ÉlanUn service télé novateur qui en offre encore plus avec l’ajout de l’appli Amazon Prime Video.Les clients de la Télé Élan […]Read More
0 NYSE Companies - November 20, 2019A.H. Belo Corporation Announces Restatement; Receives NYSE Notice Regarding Late Form 10-Q FilingDALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today in a Form 8-K filed […]Read More
0 NASDAQ Companies - November 20, 2019Mohawk Group Ranked Number 163 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500Attributes 707% Revenue Growth to the Performance of its Artificial Intelligence-Driven E-Commerce Platform and Agile Supply ChainNEW YORK, Nov. 20, 2019 […]Read More
0 NASDAQ Companies - November 20, 2019The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid ArthritisSALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics […]Read More
0 TSX Venture News - November 20, 2019Giyani Announces Grant of Stock OptionsNot for distribution to U.S. newswire services or for dissemination in the United StatesOAKVILLE, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - November 20, 2019Trevena Announces Publication of Results from Special Population Studies for OliceridineNo dose adjustments required for patients with renal impairment or patients with mild / moderate hepatic impairmentCHESTERBROOK, Pa., Nov. 20, […]Read More
0 NASDAQ Companies - November 20, 2019BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in NeurologyA single transplantation of MSC-NTF cells (NurOwn®) in ALS clinical trial participants met the primary safety endpoint and demonstrated promising […]Read More